A clinical case of a hereditary form of colorectal cancer associated with a CHEK2 gene defect

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


The article describes a clinical case of colorectal cancer with a positive family history. In the course of a molecular genetic study by NGS sequencing, a germinal c.1607delC mutation was detected in exon 15 of the CHEK2 gene (NM_007194.4). According to ClinVar, this option has uncertain clinical significance. The article provides literature data on cases of carriage of CHEK2 gene mutations. More careful monitoring of carriers of pathogenic variants in the CHEK2 gene from families with multiple manifestations of colorectal cancer is now recommended.

Full Text

Restricted Access

About the authors

Ildar R. Minniakhmetov

Republican Medical Genetic Center

Author for correspondence.
Email: minniakhmetov@gmail.com
ORCID iD: 0000-0002-7045-8215
SPIN-code: 8643-7056

Associate Professor of the Department of Medical Genetics and Fundamental Medicine, Director

Russian Federation, 74, st. Gafuri, Ufa, 450076

Marina A. Bermisheva

Ufa Branch of the Russian Academy of Sciences

Email: marina_berm@mail.ru
ORCID iD: 0000-0002-0584-3969
SPIN-code: 6220-2619

MD, Doctor of Biological Sciences, Senior Researcher

Russian Federation, Ufa

Evelina M. Kagirova

Republican Medical Genetic Center

Email: evelina.kagirova@mail.ru
ORCID iD: 0000-0003-0882-7048

Postgraduate student of the Department of Medical Genetics and Fundamental Medicine, biologist

Russian Federation, 74, st. Gafuri, Ufa, 450076

Marat G. Gordiev

LLC “National Bioservice”

Email: marat7925@gmail.com
ORCID iD: 0000-0002-3848-865X
SPIN-code: 8388-3566


Russian Federation, 17, letter A, Litovskaya st., St. Petersburg, 194100

Rita I. Khusainova

Republican Medical Genetic Center

Email: ritakh@mail.ru
ORCID iD: 0000-0002-8643-850X
SPIN-code: 4091-9326

PhD, MD, Dr. Sci. (Biol.), Professor of the Department of Medical Genetics and Fundamental Medicine, Deputy Director for Laboratory and Diagnostic Work

Russian Federation, 74, st. Gafuri, Ufa, 450076


  1. Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi: 10.1136/gutjnl-2015-310912
  2. Bray F, Colombet M, Mery L, et al, editors. Cancer Incidence in Five Continents Volume XI: Cancer Today. IARC Scientific Publication № 166. WHO; 2017.
  3. Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer [cited: 23 Feb 2022]. Available from: https://gco.iarc.fr/today
  4. Sawicki T, Ruszkowska M, Danielewicz A, et al. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers (Basel). 2021;13(9). doi: 10.3390/cancers13092025
  5. Valle L, Vilar E, Tavtigian SV, Stoffel EM. Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine. J Pathol. 2019;247(5):574–588. doi: 10.1002/path.5229
  6. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103. doi: 10.5114/pg.2018.81072
  7. Duraturo F, Liccardo R, De Rosa M, Izzo P. Genetics, diagnosis and treatment of Lynch syndrome: Old lessons and current challenges. Oncol Lett. 2019;17(3):3048–3054. doi: 10.3892/ol.2019.9945
  8. Yang J, Gurudu SR, Koptiuch C, et al. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes. Gastrointest Endosc. 2020;91(5):963–982 e962. doi: 10.1016/j.gie.2020.01.028
  9. Stolarova L, Kleiblova P, Janatova M, et al. CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate. Cells. 2020;9(12). doi: 10.3390/cells9122675
  10. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434(7035):864–870. doi: 10.1038/nature03482
  11. Cybulski C, Gorski B, Huzarski T, et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet. 2004;75(6):1131–1135. doi: 10.1086/426403
  12. Caswell-Jin JL, Gupta T, Hall E, et al. Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk. Genet Med. 2018;20(2):234–239. doi: 10.1038/gim.2017.96
  13. Sun J, Meng H, Yao L, et al. Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients. Clin Cancer Res. 2017;23(20):6113–6119. doi: 10.1158/1078-0432.CCR-16-3227
  14. Duzkale N, Oz O, Turkmenoglu TT, et al. Investigation of Hereditary Cancer Predisposition Genes of Patients with Colorectal Cancer: Single-centre Experience. J Coll Physicians Surg Pak. 2021;30(7):811–816. doi: 10.29271/jcpsp.2021.07.811
  15. Meijers-Heijboer H, Wijnen J, Vasen H, et al. The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet. 2003;72(5):1308–1314. doi: 10.1086/375121
  16. Naseem H, Boylan J, Speake D, et al. Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high-penetrance genes. Clin Genet. 2006;70(5):388–395. doi: 10.1111/j.1399-0004.2006.00698.x
  17. Cragun D, Radford C, Dolinsky JS, et al. Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory. Clin Genet. 2014;86(6):510–520. doi: 10.1111/cge.12359
  18. Pearlman R, Frankel WL, Swanson B, et al. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. JAMA Oncol. 2017;3(4):464–471. doi: 10.1001/jamaoncol.2016.5194
  19. You YN, Borras E, Chang K, et al. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Dis Colon Rectum. 2019;62(4):429–437. doi: 10.1097/DCR.0000000000001322
  20. Rosenthal ET, Evans B, Kidd J, et al. Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing. J Am Coll Radiol. 2017;14(4):561–568. doi: 10.1016/j.jacr.2016.10.003

Supplementary files

There are no supplementary files to display.

Copyright (c) 2021 Eco-Vector

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 014159 от 23.10.1995 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80673 от 23.03.2021 г

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies